Eli Lilly & Co.

Q: How do I trade LLY on Bybit?

Click the Trade button above to explore available products for Eli Lilly & Co. on Bybit, including Stocks (real equity), Perpetuals (leveraged, 24/7), xStocks (wallet-based, 24/7), and CFDs. Each suits a different trading strategy. Product availability may vary.

Q: Does Eli Lilly & Co. pay dividends?

Eli Lilly & Co.'s current dividend yield is shown in the Key Metrics section. Bybit Stocks holders receive dividend distributions when declared, while Perpetual holders receive equivalent adjustments via the funding rate.

Q: What is Eli Lilly & Co.'s P/E ratio, and what does it mean?

Eli Lilly & Co.'s P/E ratio is shown in the Key Metrics section, along with its percentile ranking relative to peers in the Pharmaceuticals sector. A higher P/E typically reflects higher growth expectations, while a lower P/E may indicate undervaluation.

Q: What financial results has Eli Lilly & Co. recently released?

The most recent quarterly results, including revenue, operating income, and net profit, are shown in the Financials section. Historical trends are available via the interactive charts.

Q: Can I trade LLY 24/7 on Bybit?

{{ticker}} Perpetuals and xStocks are available for 24/7 trading. Stocks trading follows regular market hours, with limited pre-market and post-market sessions.

Q: What payment methods can I use to buy LLY?

You can fund your Bybit account by depositing crypto, including USDT, or using a credit/debit card. Stocks, Perpetuals, and CFDs are all settled in USDT.

Q: How does buying LLY on Bybit compare to using a traditional broker?

If Stocks trading is available for Eli Lilly & Co., Bybit gives you direct equity ownership, including dividend eligibility, similar to a traditional broker. Bybit also offers leveraged derivative products, including Perpetuals and CFDs, as well as tokenized products such as xStocks, all in a single account.

LLY

www.lilly.com

Pharmaceuticals

1m5m15m1h4h1d1w

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and...

IndustryPharmaceuticalsHeadquartersLILLY CORPORATE CTR, INDIANAPOLIS, INPrimary ExchangeNYSEEmployees50,000Listing DateJul 9, 1970Websitewww.lilly.com

Key Metrics

$1.03T

38.5x

30.3x

$12.99B

$7.94

78.84%

18.77%

0.56%

Corporate Actions

Earnings ReportSep 30, 2024

FY2024 Q3 earnings reported. Diluted EPS: $1.07.

Ex-DividendNov 15, 2024

Quarterly dividend of $1.30 per share. Ex-dividend date: November 15. Payable: December 10.

Earnings ReportDec 31, 2024

FY2024 Q4 earnings reported. Diluted EPS: $4.88.

Earnings ReportDec 31, 2024

FY2024 Q4 earnings reported. Diluted EPS: $11.71.

Ex-DividendFeb 14, 2025

Quarterly dividend of $1.50 per share. Ex-dividend date: February 14. Payable: March 10.

Earnings ReportMar 31, 2025

FY2025 Q1 earnings reported. Diluted EPS: $3.06.

Ex-DividendMay 16, 2025

Quarterly dividend of $1.50 per share. Ex-dividend date: May 16. Payable: June 10.

Earnings ReportJun 30, 2025

FY2025 Q2 earnings reported. Diluted EPS: $6.29.

Ex-DividendAug 15, 2025

Quarterly dividend of $1.50 per share. Ex-dividend date: August 15. Payable: September 10.

Earnings ReportSep 30, 2025

FY2025 Q3 earnings reported. Diluted EPS: $6.21.

Ex-DividendNov 14, 2025

Quarterly dividend of $1.50 per share. Ex-dividend date: November 14. Payable: December 10.

Earnings ReportDec 31, 2025

FY2025 Q4 earnings reported. Diluted EPS: $7.39.

Earnings ReportDec 31, 2025

FY2025 Q4 earnings reported. Diluted EPS: $22.95.

Ex-DividendFeb 13, 2026

Quarterly dividend of $1.73 per share. Ex-dividend date: February 13. Payable: March 10.

Earnings ReportMar 31, 2026

FY2026 Q1 earnings reported. Diluted EPS: $8.26.

Ex-DividendMay 15, 2026

Quarterly dividend of $1.73 per share. Ex-dividend date: May 15. Payable: June 10.

Earnings ReportJun 30, 2026

FY2026 Q2 earnings reported. Diluted EPS: $7.94.

Ex-DividendAug 14, 2026

Quarterly dividend of $1.73 per share. Ex-dividend date: August 14. Payable: September 10.

FAQ about Eli Lilly & Co.

What is the current price of Eli Lilly & Co.?

›

The current price of LLY is shown in the price section above and updated in real time during regular trading hours. If you trade LLY Perpetuals on Bybit, pre-market, post-market, and overnight prices are also available.

How do I trade LLY on Bybit?

›

Does Eli Lilly & Co. pay dividends?

›

What is Eli Lilly & Co.'s P/E ratio, and what does it mean?

›

What financial results has Eli Lilly & Co. recently released?

›

Can I trade LLY 24/7 on Bybit?

›

What payment methods can I use to buy LLY?

›

How does buying LLY on Bybit compare to using a traditional broker?

›

Disclaimer

The information contained herein is provided for informational purposes only and does not constitute investment, financial, trading, or other professional advice. Trading in digital assets and securities involves substantial risk of loss, including the possible loss of all principal invested. The value of digital assets and securities may be highly volatile, and past performance is not indicative of future results. Market data displayed is sourced from third-party data providers and may be subject to delays or inaccuracies. Bybit does not warrant the accuracy, completeness, or timeliness of any information displayed. All investment decisions are made solely at the investor's own risk. Independent due diligence and consultation with a licensed financial advisor are strongly recommended before making any investment decision.

Trade LLY

Rising inflation risks and the Fed’s recent decision to raise borrowing costs have prompted Bank of America to pencil in two more interest-rate increases in South Africa this year.

Bloomberg35m ago

Japanese Yen slides as Fed hawkishness, intervention fears grow

Financia lJuice56m ago

Markets’ Eyes on the FED: FED Member Goolsbee on Inflation, Bessent on Warsh!

1h ago

US Dollar: Oil-driven support as Fed seen hiking – ING

Financia lJuice3h ago

Experts agree: Further US Dollar’s upside hinges on upcoming data and not hawkish Fed prospects